GLP-1 drugs

Keyword: GLP-1 drugs

3 results found
Copyright_markovsergei_123RF

The percentage of claimants filing claims for obesity drugs increased by 43 per cent in 2023, according to a new report by GreenShield. The report, which analyzed the insurer’s 2023 claims data, found diabetes medications saw a 13 per cent increase in cost, accounting for nine per cent of total drug costs in 2023. There […]

  • By: Staff
  • November 22, 2024 November 20, 2024
  • 09:00
Copyright_marchmeena_123RF

In Canada, the average health benefits cost trend for 2025 is estimated to be 7.4 per cent, up from five per cent in 2024, according to a new report by Aon. It found the top medical conditions driving health benefits plan costs are diabetes, autoimmune diseases (excluding diabetes), mental health, lung disorders/respiratory and cardiovascular and […]

  • By: Staff
  • November 20, 2024 November 19, 2024
  • 09:00
Copyright_marchmeena_123RF

U.S. employers’ health benefits costs are expected to increase to nearly eight per cent for 2025, the highest amount in more than a decade, according to a new survey by Business Group on Health. The survey, which polled 125 large employers, found they’re planning to continue to absorb much of the increases at least for […]

  • By: Staff
  • August 28, 2024 August 28, 2024
  • 15:00